secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001396814-23-000056
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira BioSciences appoints four new independent directors, expanding board to 12
--------------------------------------------------------------------------------

- Board increased from 10 to 12 directors; appointed Alethia Young (Audit), Marcelo Bigal (Science & Tech), Abraham Ceesay (Compensation), Michael Yang (Compensation).
- All four are independent under Nasdaq standards; bring scientific, commercial, and financial expertise.
- Appointments effective immediately; each receives standard non-employee director compensation.
- Appointments enhance racial and gender diversity on the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000056/0001396814-23-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000056/pcrx-20231006.htm
  HTML page:      https://secwatch.observer/filing/0001396814-23-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer